OpGen, Inc.

OPGN | $0.598 -5.18% 50K

(0.0% 1d) (28.4% 1m) (-31.8% 1y) (0.0% 2d) (1.7% 3d) (-1.6% 7d) (-38.64% volume)
Earnings Calendar: 2024-04-16
Market Cap: $ 7,549,691
http://www.opgen.com
Sec Filling | Patents | 40 employees

(US) OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

respiratory molecular diagnostics infectious disease antibiotics diagnostics predicting antibiotic resistance rapid diagnostics antibiotic resistance injection

add to watch list Paper trade email alert is off